Analysis of the roles of HIV-derived microRNAs

Expert Opinion on Biological Therapy

Volumn 11, Issue 1, 2011, Pages 17-29

  Narayanan, Aarthi ^a   Kehn Hall, Kylene ^a   Bailey, Charles ^a   Kashanchi, Fatah ^a  

^a GEORGE MASON UNIVERSITY   (United States)

Author keywords

cdk inhibitors; HIV 1; latency; microRNA; MiR H1; Nef; TAR

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; DICER; DROSHA PROTEIN; FLAVOPIRIDOL; HISTONE DEACETYLASE 1; MICRORNA; MICRORNA H1; NEF PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; RNA BINDING PROTEIN; ROSCOVITINE; TAR PROTEIN; TAR RNA BINDING PROTEIN; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS RNA;

B LYMPHOCYTE; BIOGENESIS; CD4+ T LYMPHOCYTE; CELL CYCLE PROGRESSION; CHROMATIN IMMUNOPRECIPITATION; DOWN REGULATION; EPSTEIN BARR VIRUS; GENE EXPRESSION; GENE SILENCING; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV ASSOCIATED DEMENTIA; HUMAN; HUMAN CYTOMEGALOVIRUS; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOMA; NONHUMAN; PATHOGENESIS; REVIEW; RNA INTERFERENCE; SIGNAL TRANSDUCTION; VIRUS GENOME; VIRUS INHIBITION; VIRUS LATENCY; VIRUS REPLICATION;

DNA VIRUSES; GENE SILENCING; HIV-1; MICRORNAS; RNA INTERFERENCE;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 78650043619     PISSN: 14712598     EISSN: None     Source Type: Journal    
DOI: 10.1517/14712598.2011.540564     Document Type: Review

References (100)

1. Bartel DP. MicroRNAs: Genomics, biogenesis, mechanism and function. Cell 2004;116(2):281-97
2. Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993;75(5):843-54
3. Reinhart BJ, Slack FJ, Basson M, et al. The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature 2000;403(6772):901-6
4. Fabian MR, Sundermeier TR, Sonenberg N. Understanding how miRNAs post-transcriptionally regulate gene expression. Prog Mol Subcell Biol 2010;50:1-20
5. Fabian MR, Sonenberg N, Filipowicz W. Regulation of mRNA translation and stability by microRNAs. Annu Rev Biochem 2010;79:351-79
6. Inui M, Martello G, Piccolo S. MicroRNA control of signal transduction. Nat Rev Mol cell Biol 2010;11(4):252-63
7. Cai Y, Yu X, Hu S, Yu J. A brief review on the mechanisms of miRNA regulation. Genomics Proteomics Bioinformatics 2009;7(4):147-54
8. Subramanian S, Steer CJ. MicroRNAs as gatekeepers of apoptosis. J Cell Physiol 2010;223(2):289-98
9. Zhang C. Novel functions of small RNA molecules. Curr Opin Mol Ther 2009;11(6):641-51
10. Chua JH, Armugam A, Jeyaseelan K. MicroRNAs: Biogenesis, function and applications. Curr Opin Mol Ther 2009;11(2):189-99
11. Ying SY, Lin SL. Intron-mediated RNA interference and microRNA biogenesis. Methods Mol Biol 2009;487:387-413
12. Perron MP, Provost P. Protein components of the microRNA pathway and human diseases. Methods Mol Biol 2009;487:369-85
13. Winter J, Jung S, Keller S, et al. Many roads to maturity: MicroRNA biogenesis pathways and their regulation. Nat Cell Biol 2009;11(3):228-34
14. Faller M, Guo F. MicroRNA biogenesis: There's more than one way to skin a cat. Biochim Biophys Acta 2008;1779(11):663-7
15. Perron MP, Provost P. Protein interactions and complexes in human microRNA biogenesis and function. Front Biosci 2008;13:2537-47
16. Cai X, Hagedorn CH, Cullen BR. Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs. RNA 2004;10(12):1957-66
17. Lee Y, Ahn C, Han J, et al. The nuclear RNase III drosha initiates microRNA processing. Nature 2003;425(6956):415-19
18. Han J, Lee Y, Yeom KH, et al. The Drosha-DGCR8 complex in primary microRNA processing. Genes Dev 2004;18(24):3016-27
19. Yi R, Qin Y, Macara IG, Cullen BR. Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes Dev 2003;17(24):3011-16
20. Kim VN. MicroRNA precursors in motion: Exportin-5 mediates their nuclear export. Trends Cell Biol 2004;14(4):156-9
21. Chendrimada TP, Gregory RI, Kumaraswamy E, et al. TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing. Nature 2005;436:740-41
22. Haase AD, Jaskiewicz L, Zhang H, et al. TRBP, a regulator of cellular PKR and HIV-1 virus expression, interacts with Dicer and functions in RNA silencing. EMBO Rep 2005;6(10):961-7
23. Kawamata T, Tomari Y. Making RISC. Trends Biochem Sci 2010;35(7):368-76
24. Schwartz DS, Hutvagner G, Du T, et al. Asymmetry in the assembly of the RNAi enzyme complex. Cell 2003;115(2):199-208
25. Parker JS, Parizotto EA, Wang M, et al. Enhancement of the seed-target recognition step in RNA silencing by a PIWI/MID domain protein. Mol Cell 2009;33(2):204-14
26. Parker JS, Roe SM, Barford D. Molecular mechanism of target RNA transcript recognition by Argonaute-guide complexes. Cold Spring Harb Symp Quant Biol 2006;71:45-50
27. Kulkarni M, Ozgur S, Stoecklin G. On track with P-bodies. Biochem Soc Trans 2010;38(pt 1):242-51
28. Zofall M, Grewal SI. RNAi-mediated heterochromatin assembly in fission yeast. Cold Spring Harb Symp Quant Biol 2006;71:487-96
29. Verdel A, Jia S, Gerber S, et al. RNAi-mediated targeting of heterochromatin by the RITS complex. Science 2004;303(5658):672-6
30. Buhler M, Moazed D. Transcription and RNAi in heterochromatic gene silencing. Nat Struct Mol Biol 2007;14:1041-8
31. Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005;120(1):15-20
32. Pfeffer S, Zavolan M, Grasser FA, et al. Identification of virus-encoded MicroRNAs. Science 2004;304(5671):734-6
33. Cai X, Schafer A, Lu S, et al. Epstein-Barr Virus microRNAs are evolutionarily conserved and differentially expressed. PLoS Pathog 2006;2:e23
34. Grundhoff A, Sullivan CS, Ganem D. A combined computational and microarray based approach identifies novel microRNAs encoded by human gamma-herpesviruses. RNA 2006;12:733-50
35. Zhu JY, Pfuhl T, Motsch N, et al. Identification of novel Epstein-barr virus microRNA genes from nasopharyngeal carcinomas. J Virol 2009;83(7):3333-41
36. Ganem D, Ziegelbauer J. MicroRNAs of Kaposi's sarcoma associated herpes virus. Semin Cancer Biol 2008;18(6):437-40
37. Dolken L, Pfeffer S, Koszinowski UH. Cytomegalovirus microRNAs. Virus Genes 2009;38(3):355-64
38. Boss IW, Plaisance KB, Renne R. Role of virus-encoded microRNAs in herpesvirus biology. Trends Microbiol 2009;17(12):544-53
39. Pfeffer S, Sewer A, Lagos-Quintana M, et al. Identification of microRNAs of the herpesvirus family. Nat Methods 2005;2(4):269-76
40. Lin J, Cullen BR. Analysis of the interaction of primate retroviruses with the human RNA interference machinery. J Virol 2007;81(22):12218-26
41. Kaul D, Ahlawat A, Gupta SD. HIV-1 genome encoded hiv1-mir-H1 impairs cellular responses to infection. Mol Cell Biochem 2009;323:143-8
42. Yeung ML, Bennasser Y, Le SY, Jeang KT. Si RNA, miRNA and HIV: Promises and challenges. Cell Res 2005;15(11-12):935-46
43. Yeung ML, Bennasser Y, Watasgu K, et al. Pyrosequencing of small non-coding RNAs in HIV-1 infected cells: Evidence for the processing of a viral-cellular double-stranded RNA hybrid. Nucleic Acids Res 2009;37(19):6575-86
44. Perez JT, Varble A, Sachidanandam R, et al. Influenza A virus-generated small RNAs regulate the switch from transcription to replication. Proc Natl Acad Sci USA 2010;107(25):11525-30
45. Pumfery A, Deng L, Maddukuri A, et al. Chromatin remodeling and modification during HIV-1 Tat-activated transcription. Curr HIV Res 2003;1:261-2741
46. Berkhout B, Gatignol A, Rabson AB, Jeang KT. TAR-independent activation of the HIV-1 LTR: Evidence that tat requires specific regions of the promoter. Cell 1990;62:757-67
47. Das AT, Klaver B, Berkhout B. The 5 and 3 TAR elements of human immunodeficiency virus exert effects at several points in the virus life cycle. J Virol 1998;72(11):9217-23
48. Bennasser Y, Le SY, Yeung ML, Jeang KT. HIV-1 encoded candidate micro-RNAs and their cellular targets. Retrovirology 2004;1:43
49. Purzycka KJ, Adamiak RW. The HIV-2 TAR RNA domain as a potential source of viral-encoded miRNA. A reconnaissance study. Nucleic Acids Symp Ser (Oxf) 2008;(52):511-12
50. Gatignol A, Buckler-White A, Berkhout B, Jeang KT. Characterization of a human TAR RNA-binding protein that activates the HIV-1 LTR. Science 1991;251(5001):1597-600
51. Klase Z, Kale P, Winograd R, et al. HIV-1 TAR element is processed by Dicer to yield a viral micro-RNA involved in chromatin remodeling of the viral LTR. BMC Mol Biol 2007;8:63
52. Klase Z, Winograd R, Davis J, et al. HIV-1 TAR miRNA protects against apoptosis by altering cellular gene expression. Retrovirology 2009;6:18
53. Ouellet DL, Plante I, Landry P, et al. Identification of functional microRNAs released through asymmetrical processing of HIV-1 TAR element. Nucleic Acids Res 2008;36(7):2353-65
54. Joseph AM, Kumar M, Mitra D. Nef: "necessary and enforcing factor" in HIV infection. Curr HIV Res 2005;3(1):87-94
55. Foster JL, Garcia JV. HIV-1 Nef: At the crossroads. Retrovirology 2008;5:84
56. Yamamoto T, Omoto S, Mizuguchi M, et al. Double-stranded nef RNA interferes with human immunodeficiency virus type 1 replication. Microbiol Immunol 2002;46(11):809-17
57. Olivetta E, Pugliese K, Bona R, et al. Cis expression of the F12 human immunodeficiency virus (HIV) Nef allele transforms the highly productive NL4-3 HIV type 1 to a replication-defective strain: Involvement of both Env gp41 and CD4 intracytoplasmic tails. J Virol 2000;74(1):483-92
58. Omoto S, Ito M, Tsutsumi Y, et al. HIV-1 nef suppression by virally encoded microRNA. Retrovirology 2004;1:44
59. Lamers SL, Fogel GB, McGrath MS. HIV-miR-H1 evolvability during HIV pathogenesis. Biosystems 2010;101(2):88-96
60. Bennasser Y, Le SY, Benkirane M, Jeang KT. Evidence that HIV-1 encodes an siRNA and a suppressor of RNA silencing. Immunity 2005;22(5):607-19
61. Perez JT, Varble A, Sachidanandam R, et al. Influenza A virus-generated small RNAs regulate the switch from transcription to replication. Proc Natl Acad Sci USA 2010;107(25):11525-30
62. Karjee S, Minhas A, Sood V, et al. The 7a accessory protein of severe acute respiratory syndrome coronavirus acts as an RNA silencing suppressor. J Virol 2010;84(19):10395-401
63. Andersson MG, Haasnoot PC, Xu N, et al. Suppression of RNA interference by adenovirus virus-associated RNA. J Virol 2005;79(15):9556-65
64. Haasnoot J, de Vries W, Geutjes EJ, et al. The Ebola virus VP35 protein is a suppressor of RNA silencing. PLoS Pathog 2007;3(6):e86
65. de Vries W, Haasnoot J, Fouchier R, et al. Differential RNA silencing suppression activity of NS1 proteins from different influenza A virus strains. J Gen Virol 2009;90(Pt 8):1916-22
66. Schnettler E, de Vries W, Hemmes H, et al. The NS3 protein of rice hoja blanca virus complements the RNAi suppressor function of HIV-1 Tat. EMBO Rep 2009;10(3):258-63
67. Coley W, Van Duyne R, Carpio L, et al. Absence of Dicer in monocytes and its regulation by HIV-1. J Biol Chem 2010;285(42):31930-43
68. Kolber MA. Development of drug resistance mutations in patients on highly active antiretroviral therapy: Does competitive advantage drive evolution. AIDS Rev 2007;9(2):68-74
69. Siliciano JD, Siliciano RF. A long-term latent reservoir for HIV-1: Discovery and clinical implications. J Antimicrob Chemother 2004;54(1):6-9
70. Baba M. Inhibitors of HIV-1 gene expression and transcription. Curr Top Med Chem 2004;4(9):871-82
71. Vrolijk MM, Harwig A, Berkhout B, Das AT. Destrabilization of the TAR hairpin leads to extension of the polyA hairpin and inhibition of HIV-1 polyadenylation. Retrovirology 2009;6:13
72. Berkhout B. Structural features in TAR RNA of human and simian immunodeficiency viruses: A phylogenetic analysis. Nucleic Acids Res 1992;20(1):27-31
73. Klaver B, Berkhout B. Evolution of a disrupted TAR RNA hairpin structure in the HIV-1 virus. EMBO J 1994;13(11):2650-9
74. Das AT, Brummelkamp TR, Westerhout EM, et al. Human immunodeficiency virus type 1 escapes from RNA interference-mediated inhibition. J Virol 2004;78(5):2601-5
75. Leonard JN, Shah PS, Burnett JC, Schaffer DV. HIV evades RNA interference directed at TAR by an indirect compensatory mechanism. Cell Host Microbe 2008;4(5):484-94
76. Berkhout B. A new Houdini act: Multiple routes for HIV-1 escape from RNAi-mediated inhibition. Future Microbiol 2009;4(2):151-4
77. Nathans R, Chu CY, Serquina AK, et al. Cellular microRNA and P bodies modulate host-HIV-1 interactions. Mol Cell 2009;34(6):696-709
78. Triboulet R, Mari B, Lin YL, et al. Suppression of microRNA-silencing pathway by HIV-1 during virus replication. Science 2007;315(5818):1579-82
79. Sung TL, Rice AP. miR-198 inhibits HIV-1 gene expression and replication in monocytes and its mechanism of action appears to involve repression of cyclin T1. PLoS Pathog 2009;5(1):e1000263
80. Ahluwalia JK, Khan SZ, Soni K, et al. Human cellular microRNA has-miR-29a interferes with viral nef protein expression and HIV-1 replication. Retrovirology 2008;5:117
81. Wang X, Ye L, Hou W, et al. Cellular microRNA expression correlates with susceptibility of monocytes/macrophages to HIV-1 infection. Blood 2009;113(3):671-4
82. Huang J, Wang F, Argyris E, et al. Cellular microRNAs contribute to HIV-1 latency in resting primary CD4+ T lymphocytes. Nat Med 2007;13(10):1241-7
83. Son J, Uchil PD, Kim YB, et al. Effective suppression of HIV-1 by artificial bispecific miRNA targeting conserved sequences with tolerance for wobble base-pairing. Biochem Biophys Res Commun 2008;374(2):214-18
84. Liu YP, Haasnoot J, ter Brake O, et al. Inhibition of HIV-1 by multiple siRNAs expressed from a single microRNA polycistron. Nucleic Acids Res 2008;36(9):2811-24
85. Zhang J, Rossi JJ. Strategies in designing multigene expression units to downregulate HIV-1. Methods Mol Biol 2010;623:123-36
86. Murakami T, Yamamoto N. Role of CXCR4 in HIV infection and its potential as a therapeutic target. Future Microbiol 2010;5(7):1025-39
87. Chable-Bessia C, Meziane O, Latreille D, et al. Suppression of HIV-1 replication by microRNA effectors. Retrovirology 2009;6:26
88. Deng L, Ammosova T, Pumfery A, et al. HIV-1 Tat interaction with RNA polymerase II C-terminal domain (CTD) and a dynamic association with CDK2 induce CTD phosphorylation and transcription from HIV-1 promoter. J Biol Chem 2002;277(37):33922-9
89. Romano G, Kasten M, De Falco G, et al. Regulatory functions of Cdk9 and cyclin T1 in HIV tat transactivation pathway gene expression. J Cell Biochem 1999;75(3):357-68
90. Nekhai S, Jeang KT. Transcriptional and post-transcriptional regulation of HIV-1 gene expression: Role of cellular factors for Tat and Rev. Future Microbiol 2006;1:417-26
91. Kim YK, Bourgeois CF, Isel C, et al. Phosphorylation of the RNA polymerase II carboxyl-terminal domain by CDK9 is directly responsible for human immunodeficiency virus type 1 Tat-activated transcriptional elongation. Mol Cell Biol 2002;22(13):4622-37
92. De la Fuente C, Maddukuri A, Kehn K, et al. Pharmacological cyclin-dependent kinase inhibitors as HIV-1 antiviral therapeutics. Curr HIV Res 2003;1(2):131-52
93. Pumfrey A, de la Fuente C, Berro R, et al. Potential use of pharmacological cyclin-dependent kinase inhibitors as anti-HIV therapeutics. Curr Pharm Des 2006;12(16):1949-61
94. Ali A, Ghosh A, Nathans RS, et al. Identification of flavopiridol analogues that selectively inhibit positive transcription elongation factor (P-TEFb) and block HIV-1 replication. Chembiochem 2009;10(12):2072-80
95. Chao SH, Fujinaga K, Marion JE, et al. Flavopiridol inhibits P-TEFb and blocks HIV-1 replication. J Biol Chem 2000;275(37):28345-8
96. Fischer PM, Gianella-Borradori A. Recent progress in the discovery and development of cyclin-dependent kinase inhibitors. Expert Opin Investig Drugs 2005;14(4):457-77
97. Wang Y, Liu XY, De Clercq E. Role of the HIV-1 positive elongation factor P-TEFb and inhibitors thereof. Mini Rev Med Chem 2009;9(3):379-85
98. Agbottah E, de la Fuente C, Nekhai S, et al. Antiviral activity of CYC202 in HIV-1-infected cells. J Biol Chem 2005;280(4):3029-42
99. Guendel I, Agbottah ET, Kehn-Hall K, Kashanchi F. Inhibition of human immunodeficiency virus type-1 by cdk inhibitors. AIDS Res Ther 2010;7(1):7
100. Carpio L, Klase Z, Coley W, et al. MicroRNA machinery is an integral component of drug-induced transcription inhibition in HIV-1 infection. J RNAi Gene Silencing 2010;6(1):386-400